Latest Europe News

Provaris Energy and Yinson have completed the design of a groundbreaking large-scale liquid CO2 tank for maritime use and are forming a joint venture to commercialize this innovation, aiming to scale carbon capture supply chains and reduce costs.

Green Critical Minerals has completed commissioning of the first module of its commercial-scale VHD Graphite Production Plant, setting the stage for scalable manufacturing and targeted revenue in early 2026.

Vection Technologies has partnered with Rider Srl to co-develop ACRobot, a modular AI-driven robotic platform aimed at revolutionizing open-field agriculture and precision farming.

Harvest Technology Group reports it is one year ahead of its 3-Year Pathway to Profit plan, forecasting a significant reduction in EBITDA loss for FY25 and unveiling plans for its AI-powered NEON platform launch in 1H26.

CSL has secured FDA approval for ANDEMBRY®, a pioneering treatment for hereditary angioedema, enabling an immediate US launch with promising clinical results. This milestone marks a significant advance in managing a rare but debilitating condition.

Linius Technologies secures $3.3 million through share placement and convertible notes, appointing former AFL CEO Andrew Demetriou to its board as it accelerates commercial momentum under new leadership.

Australian Strategic Materials (ASM) has announced an underwritten share purchase plan to raise up to A$3 million, supporting its advancing Dubbo Project and ramp-up of the Korean Metals Plant. The company also outlines ambitions for a US metals facility amid strong government backing and strategic partnerships.

Hazer Group unveils a strategic alliance with engineering giant KBR to fast-track its low-cost clean hydrogen technology, targeting major global markets with a capex-lite licensing model.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Dimerix has reached a key milestone by dosing 200 adult patients in its Phase 3 ACTION3 trial for FSGS, progressing steadily toward full recruitment expected in late 2025.

Vulcan Energy has received building permits for its 30MW geothermal renewable energy plant in Germany, advancing its goal of carbon-neutral lithium production for Europe’s battery industry.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.